← Nazad


De Angelis R



Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017;18(8):1022-39.[Šekerija M]

Autori: Anderson LA, Ardanaz E, Bella F, Botta L, Capocaccia R, Comber H, De Angelis R, Dimitrova N, Gatta G, Kaire I, Leinonen MK, Mallone S, Otter R, RARECAREnet working group, Siesling S, Stiller CA, Trama A, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP
Godina: 2017

Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer. 2017;77:140-52. [Šekerija M]

Autori: Agius D, Amash H, Ardanaz E, Capocaccia R, Chirlaque MD, Colonna M, Dal Maso L, De Angelis R, EUROCARE-5 Working Group, Kowalska A, Larranaga N, Mallone S, Pacini F, Rubió-Casadevall J, Serraino D, Tavilla A, van Dijk BAC, Virdone S
Godina: 2017

(Šekerija M) Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study. European journal of cancer. 2015.

Autori: Brewster DH, Dal Maso L, De Angelis R, Minicozzi P, Osca-Gelis G, Sant M
Godina: 2015